<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00004418</url>
  </required_header>
  <id_info>
    <org_study_id>199/13312</org_study_id>
    <secondary_id>Nutricia-Loma Linda</secondary_id>
    <secondary_id>KKI-FDR000685</secondary_id>
    <nct_id>NCT00004418</nct_id>
  </id_info>
  <brief_title>Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy</brief_title>
  <official_title>Study of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With Adrenoleukodystrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hugo W. Moser Research Institute at Kennedy Krieger, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hugo W. Moser Research Institute at Kennedy Krieger, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      OBJECTIVES: I. Evaluate the clinical efficacy of combination glyceryl trierucate and glyceryl
      trioleate (Lorenzo's Oil) therapy in boys with X-linked adrenoleukodystrophy.

      II. Compare the frequency and severity of neurological disability of study patients with
      untreated historical controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROTOCOL OUTLINE: This is an open label study. Patients must follow dietary instructions as
      provided by the investigator. Patients receive 2-4 tablespoons of a mixture of glyceryl
      trierucate and glyceryl trioleate oil once daily. Patients complete a neuropsychological
      scoring scale questionnaire to measure neurological disability. Patients undergo physical
      examinations including magnetic resonance imaging and magnetic resonance spectroscopy of the
      head.

      Patients are followed monthly for 6 months, then every 3 months until death.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    No funding and moved to expanded access
  </why_stopped>
  <start_date>April 1998</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>neurological disability</measure>
    <time_frame>6 months post intervention, then every 3 months until age 13 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>magnetic resonance imaging of the head</measure>
    <time_frame>yearly</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>very long chain fatty acids (VLCFA)</measure>
    <time_frame>every month during first year, then every 1-3 months</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Adrenoleukodystrophy</condition>
  <arm_group>
    <arm_group_label>GTO/GTE treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Treatment with GTO/GTE orally; 30-60 ml daily for study period</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>glyceryl trierucate</intervention_name>
    <description>Glyceryl trierucate is an oil to reduce very long chain fatty acids</description>
    <arm_group_label>GTO/GTE treatment</arm_group_label>
    <other_name>Lorenzo's oil</other_name>
    <other_name>GTE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>glyceryl trioleate</intervention_name>
    <description>Patients receive 2-4 tablespoons of a mixture of glyceryl trierucate and glyceryl trioleate oil once daily.</description>
    <arm_group_label>GTO/GTE treatment</arm_group_label>
    <other_name>Lorenzo's Oil</other_name>
    <other_name>GTO</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Biochemically proven asymptomatic X-linked adrenoleukodystrophy

          -  Platelet count in normal range
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerald V Raymond, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hugo W. Moser Research Institute at Kennedy Krieger, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kennedy Krieger Institute</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287-6681</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 1999</study_first_submitted>
  <study_first_submitted_qc>October 18, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 1999</study_first_posted>
  <last_update_submitted>September 17, 2014</last_update_submitted>
  <last_update_submitted_qc>September 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hugo W. Moser Research Institute at Kennedy Krieger, Inc.</investigator_affiliation>
    <investigator_full_name>Gerald Raymond</investigator_full_name>
    <investigator_title>Associate Professor of Neurology, Johns Hopkins University School of Medicine</investigator_title>
  </responsible_party>
  <keyword>adrenoleukodystrophy</keyword>
  <keyword>inborn errors of metabolism</keyword>
  <keyword>rare disease</keyword>
  <keyword>sphingolipidoses</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adrenoleukodystrophy</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>April 13, 2016</submitted>
    <returned>May 17, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

